Lederer & Associates Investment Counsel Elevance Health, Inc. Transaction History

Lederer & Associates Investment Counsel

$142 Million
Q3 2024

A detailed history of Lederer & Associates Investment Counsel transactions in Elevance Health, Inc. stock. As of the latest transaction made, Lederer & Associates Investment Counsel holds 4,088 shares of ELV stock, worth $1.74 Million. This represents 1.5% of its overall portfolio holdings.

Number of Shares

4,088

Previous 4,098 0.24%

Holding current value

$1.74 Million

Previous $2.22 Million 4.28%

% of portfolio

1.5%

Previous 1.61%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$500.12 - $562.29 $5,001 - $5,622	-10 Reduced 0.24%	4,088 $2.13 Million
Q2 2024 Aug 02, 2024	SELL	$497.49 - $547.8 $101,487 - $111,751	-204 Reduced 4.74%	4,098 $2.22 Million
Q1 2024 Apr 29, 2024	SELL	$464.61 - $519.96 $3,716 - $4,159	-8 Reduced 0.19%	4,302 $2.23 Million
Q4 2023 Jan 19, 2024	SELL	$433.51 - $488.06 $21,241 - $23,914	-49 Reduced 1.12%	4,310 $2.03 Million
Q3 2023 Oct 23, 2023	SELL	$414.13 - $475.93 $4,969 - $5,711	-12 Reduced 0.27%	4,359 $1.9 Million
Q2 2023 Aug 04, 2023	SELL	$436.33 - $496.2 $17,016 - $19,351	-39 Reduced 0.88%	4,371 $1.94 Million
Q1 2023 Apr 17, 2023	BUY	$446.3 - $502.2 $136,567 - $153,673	306 Added 7.46%	4,410 $2.03 Million
Q4 2022 Jan 12, 2023	SELL	$465.23 - $546.77 $45,592 - $53,583	-98 Reduced 2.33%	4,104 $2.11 Million
Q3 2022 Nov 14, 2022	BUY	$445.98 - $507.0 $18,285 - $20,787	41 Added 0.99%	4,202 $1.91 Million
Q2 2022 Aug 09, 2022	SELL	$444.32 - $529.84 $546,513 - $651,703	-1,230 Reduced 22.82%	4,161 $2.01 Million
Q1 2022 May 24, 2022	SELL	$428.44 - $502.48 $84,831 - $99,491	-198 Reduced 3.54%	5,391 $2.65 Million
Q4 2021 Jan 24, 2022	SELL	$370.08 - $467.67 $59,582 - $75,294	-161 Reduced 2.8%	5,589 $2.59 Million
Q3 2021 Oct 22, 2021	SELL	$357.51 - $398.13 $3,217 - $3,583	-9 Reduced 0.16%	5,750 $2.14 Million
Q2 2021 Jul 23, 2021	BUY	$352.19 - $401.9 $85,934 - $98,063	244 Added 4.42%	5,759 $2.2 Million
Q1 2021 Apr 19, 2021	SELL	$287.7 - $371.31 $52,649 - $67,949	-183 Reduced 3.21%	5,515 $1.98 Million
Q4 2020 Jan 25, 2021	SELL	$270.17 - $333.15 $179,122 - $220,878	-663 Reduced 10.42%	5,698 $1.83 Million
Q3 2020 Jan 13, 2021	SELL	$245.73 - $284.63 $28,996 - $33,586	-118 Reduced 1.82%	6,361 $1.71 Million
Q2 2020 Jul 14, 2020	SELL	$203.3 - $300.59 $2,033 - $3,005	-10 Reduced 0.15%	6,479 $1.7 Million
Q1 2020 Apr 20, 2020	BUY	$174.68 - $307.74 $132,582 - $233,574	759 Added 13.25%	6,489 $1.47 Million
Q4 2019 Feb 07, 2020	BUY	$234.82 - $306.42 $55,182 - $72,008	235 Added 4.28%	5,730 $1.73 Million
Q3 2019 Oct 07, 2019	BUY	$237.69 - $310.48 $48,726 - $63,648	205 Added 3.88%	5,495 $1.32 Million
Q2 2019 Jul 19, 2019	BUY	$236.25 - $293.76 $42,525 - $52,876	180 Added 3.52%	5,290 $1.49 Million
Q1 2019 Apr 12, 2019	BUY	$248.42 - $317.42 $1.27 Million - $1.62 Million	5,110 New	5,110 $1.47 Million

Others Institutions Holding ELV

# of Institutions

1,856

Shares Held

204M

Call Options Held

1.02M

Put Options Held

View Full List

About Elevance Health, Inc.

Ticker ELV
Exchange NYSE
Sector Healthcare
Industry Healthcare Plans
Shares Outstandng 240,000,992
Market Cap $102B
Description
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions....

More about ELV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lederer & Associates Investment Counsel, based on Form 13F filings with the SEC.

News

Stay updated on Lederer & Associates Investment Counsel with notifications on news.

Account

Lederer & Associates Investment Counsel Elevance Health, Inc. Transaction History